With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.103878-58-6,5-Bromothiazole-4-carboxylic acid,as a common compound, the synthetic route is as follows.
(b) 5-bromo-N-cyclopropyl- 1, 3-thiazole-4-carboxam ide To a solution of 5-bromo-1,3-thiazole-4-carboxylic acid (3.09 g, 14.85 mmol) in DCM (75 mL) was added DIPEA (5.17 mL, 29.71 mmol) followed by cyclopropylamine (1.18 mL, 17.08 mmol) and HATU (6.21 g, 16.34 mmol). The reaction mixture was allowed to stir at room temperature for 6 h. The mixture was then diluted with H20 (50 mL) and the layers were separated. The aqueous layer was further extracted with DCM (3 x 25 mL) and the combined organics dried over MgSO4, filtered and concentrated under reduced pressure. The crude reaction product was purified by flash chromatography eluting with a gradient system of 0-50% EtOAc in Petroleum ether (40-60) to give 5-bromo-N-cyclopropyl-1,3- thiazole-4-carboxamide (2.88 g, 78 % yield) as a white solid. LC-MS (Method D) 247.2/249.2 [M+H] RT 1.82 mm
103878-58-6, The synthetic route of 103878-58-6 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; REDX PHARMA PLC; RATCLIFFE, Andrew; HUXLEY, Anthony; LYTH, David; NOONAN, Gary; KIRK, Ralph; UOSIS-MARTIN, Mario; STOKES, Neil; WO2015/155549; (2015); A1;,
Thiazole | C3H3NS – PubChem
Thiazole | chemical compound | Britannica